MedTrace Logo

Dairy Consumption During a High-intensity, High-volume Training Week in Young Athletes

NCT03947801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-06-02

No results posted yet for this study

Summary

Our proposed study is a 5-d double-blind randomised cross-over trial, seeking to simulate a training identification camp in competitive adolescent soccer players

The purpose of the proposed study is to investigate whether increased protein consumption by Greek yogurt, compared to an isoenergetic carbohydrate (CHO) control supplement, consumed immediately following exercise training, prior to sleep and between breakfast and lunch, for a week during an intense training period (high volume, high intensity) will:

* Attenuate the pro-inflammatory response (cytokines, acute phase proteins)
* Reduced the severity of muscle damage and impairment (creatine kinase)
* Maintain performance

Secondary outcome measures:

\- Increase bone turnover (in favour of formation)

Conditions

  • Inflammatory Response
  • Sports Performance

Interventions

OTHER

Greek Yogurt

Female competitive soccer players (11-16y) will consume 0% plain Greek yogurt immediately following the training session, 1 h prior to bedtime, as well as one serving between breakfast and lunch on the subsequent day.

OTHER

Isoenergetic carbohydrate

Female competitive soccer players (11-16y) will consume an isoenergetic carbohydrate supplement immediately following the training session, 1 h prior to bedtime, as well as one serving between breakfast and lunch on the subsequent day.

Sponsors & Collaborators

  • Brock University

    lead OTHER

Principal Investigators

  • Panagiota Klentrou, PhD · Brock University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-11-23
Completion
2019-11-23

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03947801 on ClinicalTrials.gov